Pet Cancer Therapeutics Market trends research and projections for 2018-2024
Date: 2018-10-24   Author: Rahul Sankrityayan  Category: #market

Pet Cancer Therapeutics Market trends research and projections for 2018-2024

Pet Cancer Therapeutics Market size to exceed USD 300 million by 2024, as per a new research report by Global Market Insights, Inc.Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years.

High cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion.

Chemotherapy has been the mainstream medication for pet cancers till recent times. However, immunological vaccines entered the market and are gaining significant market share. With number of chemotherapy drugs in pipeline, the industry should witness considerable growth over the coming years.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2017

Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth.

Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types. This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth.

U.S. pet cancer therapeutics market holds the largest revenue share in 2016. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth.

Australia pet cancer therapeutics market held highest regional revenue share in 2016 owing to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2017

Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, Karyopharms Verdinexor. The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition.



About Author


Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for AlgosOnline, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in t...

Read More

More from Rahul


Post Recommendents

IT giant Cognizant acquires Dublin-based fintech firm Meritsoft
Author: Ojaswita Kutepatil

The company with this acquisition will leverage Meritsoft’s know-how to help clients transform business for the digital era.

American IT conglomerate, Cogni...


Hops material segment of Non-Alcoholic Wine and Beer Market will witness CAGR over 8% by 2024
Author: Rahul Sankrityayan

Shifting consumer preferences towards healthier alternatives is among the key factor propelling the non-alcoholic wine and beer market size. Factors such as religious restrictions, rising consumer spending across developing countries along with fa...


Matcha market from personal care & cosmetic application will witness 3.5% by 2024
Author: Rahul Sankrityayan

Rising consumption rates along with increasing health awareness of nutritious food & beverages will propel matcha demand. This rise in demand can be attributed to its nutritional benefits, unique flavor and texture along with its extreme versa...